{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-21-005448","form_type":"8-K","ticker":"BCRX","cik":"0000882796","company_name":"BIOCRYST PHARMACEUTICALS INC","filed_at":"2021-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:21.060291+00:00","generated_at":"2026-06-29T23:40:28.250679+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"BioCryst Chief Business Officer Megan Sniecinski Departs","bullets":["Megan Sniecinski, Chief Business Officer, separated from BioCryst on July 28, 2021.","No successor announced as of the filing date.","Reason for departure not specified in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-21-005448","json":"https://secwatch.observer/filing/0001171843-21-005448.json","markdown":"https://secwatch.observer/filing/0001171843-21-005448.md","text":"https://secwatch.observer/filing/0001171843-21-005448.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882796/000117184321005448/0001171843-21-005448-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882796/000117184321005448/f8k_080321.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T23:40:28.250679+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"16ea6e9e55","claim":"Megan Sniecinski departed as Chief Business Officer at BIOCRYST PHARMACEUTICALS INC.","evidence_excerpt":"On July 28, 2021, it was determined that Megan Sniecinski, Chief Business Officer of BioCryst Pharmaceuticals, Inc. (the “Company”), would separate from employment with the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/882796/000117184321005448/0001171843-21-005448-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"separated"},{"label":"Role","value":"Chief Business Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}